EB
ECLIPSE BIOINNOVATIONS, INC.
SEC filingBiotechnology · San Diego, CA
Amount raised$4.9Msold at filing
Total offering$7.2M$2.3M still open
Investors in the raise7count reported to the SEC
FiledNov 20, 2025first sale Nov 5, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Peter ChuExecutive Officer, Director
Daniel VasellaDirector
Edmond WongDirector
Eugene YeoDirector
Executive officers, directors and promoters as listed on the Form D.